Globeflex Capital’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
BIP
MA
RHJA
Globeflex Capital's UTMD Position: Q4 2025 in Review
Globeflex Capital sold out of Utah Medical Products (UTMD) in Q4 2025, closing a stake of 6,336 shares — an estimated $399K sold.
Globeflex Capital first reported a position in UTMD in Q2 2020 and held it in 22 quarters. The position peaked at $976K in Q4 2022. 117 funds tracked by Wall St. Rank hold UTMD as of Q4 2025.
- Globeflex Capital reported no remaining Utah Medical Products position as of Q4 2025 after selling out during the quarter.
- Globeflex Capital sold 6,336 Utah Medical Products shares in Q4 2025, an estimated $399K.
- Globeflex Capital first reported a position in Utah Medical Products in Q2 2020 and held it in 22 quarters.
- Globeflex Capital's Utah Medical Products position peaked at $976K in Q4 2022.
- 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2025.
Based on Globeflex Capital's 13F filing for Q4 2025, filed 11 Feb 2026.